Work

Cardiovascular Profile of Dihydroergotamine Mesylate (DHE) Delivered by the POD® Device Compared to D.H.E. 45® for Injection from the INP104-101 Clinical Trial (P2.10-017)

Year: 2019

Type: article

Source: Neurology

DOI: 10.1212/wnl.92.15_supplement.p2.10-017

Authors: Karen Craig, John Hoekman, Maria Jeleva, Kelsey Satterly, Jason Lickliter, Stephen Shrewsbury

Institution: Impel Neuropharma (United States)

Language: English

Topic: Migraine and Headache Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389441210

FWCI:

Cites:

Cited by:

Related to: 10